z-logo
open-access-imgOpen Access
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population
Author(s) -
Rulan Griesel,
Phumla Sinxadi,
Aida N. Kawuma,
John A. Joska,
Simiso Sokhela,
Godspower Akpomiemie,
François Venter,
Paolo Denti,
David W. Haas,
Gary Maartens
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac290
Subject(s) - dolutegravir , medicine , adverse effect , pharmacokinetics , population , oncology , pharmacogenetics , pharmacology , viral load , antiretroviral therapy , virology , genetics , genotype , biology , human immunodeficiency virus (hiv) , gene , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom